[
  {
    "ts": null,
    "headline": "Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike",
    "summary": "Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.",
    "url": "https://finnhub.io/api/news?id=2a912aff353e614575e08703b5de5dd097a8f9538dc05efa70bbf8eae761f2e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736270606,
      "headline": "Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike",
      "id": 132304230,
      "image": "",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.",
      "url": "https://finnhub.io/api/news?id=2a912aff353e614575e08703b5de5dd097a8f9538dc05efa70bbf8eae761f2e7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=7d2c71d157c63e52d9f43ce654f54f6a7ce25f8f9107e03dd749549d90ddd81a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736267880,
      "headline": "Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 132323915,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=7d2c71d157c63e52d9f43ce654f54f6a7ce25f8f9107e03dd749549d90ddd81a"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand",
    "summary": "Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.",
    "url": "https://finnhub.io/api/news?id=9f8dd361055bf4d2fa868187ff77861ae36345f652a6673c0f9e8501fa86eea9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736267193,
      "headline": "Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand",
      "id": 132302354,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/c4618e69192265b5b79b95e66c15fe9f",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.",
      "url": "https://finnhub.io/api/news?id=9f8dd361055bf4d2fa868187ff77861ae36345f652a6673c0f9e8501fa86eea9"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death",
    "summary": "The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.",
    "url": "https://finnhub.io/api/news?id=abbde67330758bad4adee5c3d24e75bcc47013f4c7b2c6acea94c0f903118fc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736254740,
      "headline": "Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death",
      "id": 132301064,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.",
      "url": "https://finnhub.io/api/news?id=abbde67330758bad4adee5c3d24e75bcc47013f4c7b2c6acea94c0f903118fc9"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer (PFE) is a Top Value Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=84996e20393f67c7c4e2619fb07087878efe64fdbf4e465338022a90e39f68c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736260813,
      "headline": "Why Pfizer (PFE) is a Top Value Stock for the Long-Term",
      "id": 132304778,
      "image": "https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=84996e20393f67c7c4e2619fb07087878efe64fdbf4e465338022a90e39f68c5"
    }
  },
  {
    "ts": null,
    "headline": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
    "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=a323b2b69c7124413ff5965894213050c9d502205fdccdcc0a46b0aaa16eefe1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736258417,
      "headline": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
      "id": 132301792,
      "image": "https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=a323b2b69c7124413ff5965894213050c9d502205fdccdcc0a46b0aaa16eefe1"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
    "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
    "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736249479,
      "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
      "id": 132302431,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403479106/image_1403479106.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
      "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0"
    }
  },
  {
    "ts": null,
    "headline": "Investing $50,000 in Each of These 5 Stocks Could Make You Nearly $17,500 in Passive Income in 2025",
    "summary": "If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal.  One of the easiest is to buy high-yield dividend stocks.  Investing $50,000 in each of these five stocks could make you nearly $17,500 in passive income in 2025.",
    "url": "https://finnhub.io/api/news?id=c881fa67b04acbf91560090db46f52e5efe0a64b0ccff1c917c4f08139e5ccea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736246760,
      "headline": "Investing $50,000 in Each of These 5 Stocks Could Make You Nearly $17,500 in Passive Income in 2025",
      "id": 132298452,
      "image": "https://g.foolcdn.com/editorial/images/802982/hands-behind-head-young-man.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal.  One of the easiest is to buy high-yield dividend stocks.  Investing $50,000 in each of these five stocks could make you nearly $17,500 in passive income in 2025.",
      "url": "https://finnhub.io/api/news?id=c881fa67b04acbf91560090db46f52e5efe0a64b0ccff1c917c4f08139e5ccea"
    }
  },
  {
    "ts": null,
    "headline": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
    "summary": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
    "url": "https://finnhub.io/api/news?id=9494af34e25e8500c7c49437db21578bbb302d197e5e8d589c04e4a1912e6d7b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736236610,
      "headline": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
      "id": 132299398,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9494af34e25e8500c7c49437db21578bbb302d197e5e8d589c04e4a1912e6d7b"
    }
  }
]